|
|
||||||||
2Rammelkamp Center for Education and Research, MetroHealth Medical Center, and 1Department of Physiology and Biophysics, Case Western Reserve University School of Medicine, Cleveland, Ohio
Submitted 18 September 2005 ; accepted in final form 13 November 2005
| ABSTRACT |
|---|
|
|
|---|
ion channels; renal nephron; immunoprecipitation; immunofluorescence; subcellular localization; polyclonal antibodies
Essentially, all cells of the kidney have the capacity to respond to hormones, growth factors, and paracrine substances through GPCRs linked to PLC and downstream activation of Ca2+ signaling events. In each cell type found in the nephron, the rise in intracellular Ca2+ concentration ([Ca2+]i) initiated by receptor stimulation is linked to a specific cellular function. For example, stimulation of mesangial cells of the glomerulus by angiotensin II will increase [Ca2+]i and cause contraction with associated changes in capillary loop blood flow and glomerular filtration (30). Increases in [Ca2+]i of the podocyte following stimulation by bradykinin or angiotensin II will influence contractile proteins of the podocyte foot structures and modulate filtration via the slit diaphragm (23). Activation of proximal tubule cells by low concentrations of parathyroid hormone will increase [Ca2+]i (33), which presumably plays a role in Ca2+ and phosphate homeostasis. Vasopressin has been shown to induce Ca2+ influx across the apical membrane of renal collecting duct cells, and the subsequent alterations in [Ca2+]i affect Na+ reabsorption in these tubules (7, 29, 35). There are receptors for thrombin, endothelin, EGF, TNF, PDGF, atrial natriuretic factor, leukotrienes, and thromboxanes to list a few, which are linked to PLC in various cell types of the nephron. Furthermore, the constant osmotic challenge posed by the preurine to the tonicity of the tubular epithelia necessitates regulation of cell volume. Again, Ca2+ signaling is important in this process (32, 38). Thus a possible and perhaps critical role for TRPC channels in glomerular filtration, salt and water retention, pH balance, and control of renal vascular resistance seems likely, but a comprehensive examination of TRPC channels in different regions of the nephron has not been performed. Wang et al. (36) examined the expression of TRPC channels in a mouse mesangial cell line (MMC). Using RT-PCR, these investigators found message for TRPC1 and TRPC4, which was confirmed at the protein level by Western blot and immunofluorescence analysis. Similarly, kidney sections stained positive for TRPC4 immunoreactivity in the glomerulus. Facemire et al. (5) found a low level of TRPC1, -C3, -C4, -C5, and -C6 immunoreactivity in glomeruli, whereas preglomerular resistance vessels expressed high levels of TRPC1, -C3, and -C6 relative to that found in the aorta. In a study by Lee-Kwon et al. (15), TRPC4, but not TRPC5, mRNA and immunoreactivity were detected in rat renal medullary descending vasa recta. Bandyopadhyay et al. (1) found TRPC1, TRPC3, and TRPC6 in polarized Madin-Darby canine kidney cells in culture. TRPC3 was localized to the apical membrane, TRPC1 was found primarily in the basolateral membrane, and TRPC6 was present in both locations. Finally, two recent studies (25, 37) have implicated TRPC6 in glomerulosclerosis and reported protein expression in glomerulus and isolated podocytes in culture. To date, these are the only published reports of TRPC channel expression in cells of the kidney.
The purpose of the present study was to determine the distribution of TRPC channels in different regions of rat kidney. Using antibodies directed against two different epitopes in each TRPC channel protein, we were unable to detect the presence of TRPC4, -C5, or -C7. However, immunofluorescence analysis and immunoprecipitation followed by Western blot analysis showed that TRPC1, TRPC3, and TRPC6 channels are differentially expressed in various nephron segments, suggesting that these channels play an important role in Ca2+ signaling events in these regions.
| METHODS |
|---|
|
|
|---|
1-subunit; Upstate Biotechnology); mouse anti-Na+/Ca2+ exchanger (NCX; Swant); and mouse anti-peanut lectin (Sigma). Cell culture. M1 and IMCD3 cells were obtained from the American Type Culture Collection and cultured in a 1:1 mixture of DMEM and Hams F-12 medium containing 2.5 mM L-glutamine, 1% penicillin-streptomycin-neomycin solution (GIBCO), 15 mM HEPES, 0.5 mM Na-pyruvate, and 1.2 g/l Na-bicarbonate at 37°C. M1 cells were supplemented with 0.005 mM dexamethasone, 5% heat-inactivated FBS, whereas IMCD3 cells were supplemented with 10% FBS. Rat glomerular podocytes and mesangial cells, isolated and cultured as previously described (10, 27), were kindly provided by Dr. John R. Sedor (Case Western Reserve Univ.). Spodoptera frugiperda (Sf9) cells were obtained from American Type Culture Collection and cultured as previously described (12, 13) using Graces Insect Medium supplemented with 2% lactalbumin hydrolysate, 2% yeastolate solution, 2 mM L-glutamine, 10% FBS, and 1% penicillin-streptomycin-neomycin.
Cells on permeable supports. M1 and IMCD3 cells were plated at a density of 1 x 105/well and grown to confluence on 24-mm Transwell culture chambers (Corning Costar). Resistance measurements were made with a Millicell ERS epithelial volt-ohmmeter (Millipore, Allen, TX) as described by the manufacturer.
Preparation of rat kidney lysates. Kidneys isolated from adult Sprague-Dawley rats were minced and suspended in lysis buffer containing 150 mM NaCl, 10 mM Tris·HCl (pH 7.5), and 0.1% deoxycholate. The tissue suspension was homogenized on ice using a Brinkman PT10/35 Polytron fitted with a 10-mm generator (3 x 10-s pulses at a power setting of 5). Homogenates/lysates were centrifuged at 6,000 g for 10 min at 4°C to remove tissue debris. The resulting supernatant was incubated at 4°C for 30 min and subsequently subjected to centrifugation at 100,000 g for 60 min at 4°C to remove unsolubilized membrane fragments. The resulting supernatants/lysates were used immediately for immunoprecipitation experiments. All experimental protocols involving the use of animals were approved by and performed in compliance with the Case Western Reserve University Institutional Animal Care and Use Committee guidelines.
Isolation of glomeruli and tubules.
Kidneys were removed from adult Sprague-Dawley rats, and the cortex and medulla were isolated by dissection. Cortex, minced into
1-mm3 pieces, was gently pressed through a 106-µm cell strainer using a flattened pestle. The filtrate was passed through a new 100-µm cell strainer. The filtrate was collected and passed through a 70-µm cell strainer. The tubule fraction was passed through the strainer and suspended in 5 ml of buffer containing 137 mM NaCl, 2.7 mM KCl, 1 mM Na2HPO4, and 10 mM HEPES (HBSS) and centrifuged at 12,000 g for 30 min at 4°C. The resulting tubule pellet was resuspended in lysis buffer. Glomeruli, which accumulated on the 70-µm strainer, were washed with 5 ml of HBSS and collected. The glomerular suspension, which by microscopic inspection was
90% glomeruli, was subjected to centrifugation at 200 g for 5 min. The supernatant was discarded, and the glomerular pellet was resuspended in lysis buffer.
Immunoprecipitations and immunoblots. Tissue lysates were precleared by adding control IgG together with protein A/G agarose beads for 1 h at 4°C. Precleared lysates were incubated with different TRPC-specific antibodies, and the immunocomplexes were captured by incubation with protein A/G agarose beads at 4°C for 12 h. Beads were pelleted, washed four times with lysis buffer, resuspended in 100 µl of 2x SDS sample buffer, and boiled for 3 min. Cell lysates and immunoprecipitated proteins were fractionated by SDS-PAGE and electrotransferred to polyvinylidene difluoride membranes (100 V for 1 h) in Tris-glycine buffer. Blots were probed with the indicated primary antibody and detected, following incubation with horseradish peroxidase-conjugated anti-rabbit IgG, by a SuperSignal West Pico chemiluminescent substrate (Pierce). The figures show representative results from experiments repeated at least three times.
Immunofluorescence.
Frozen sections (6 µm) from adult rat kidneys were fixed in paraformaldehyde for 30 min. The sections were briefly rinsed in PBS and subsequently incubated with blocking solution containing 3% IgG-free BSA (Vector Laboratories), 10% normal donkey serum, and 0.1% Triton X-100 for 1 h at room temperature. Sections were incubated with the indicated primary antibody overnight at 4°C. After being washed three times for 5 min with PBS at room temperature, the sections were incubated with Alexa 488- or Alexa 594-conjugated anti-rabbit IgG for 1 h at room temperature. Sections were washed three times with PBS for 5 min and mounted with Prolong Gold antifade medium (Molecular Probes). Images were acquired using a Leica DMIRE2 fluorescence microscope equipped with a computer-controlled mechanical stage and a SPOT RT camera. To obtain high-resolution dual-fluorescence images of the entire kidney cross section, filter cube selection, stage movement, and image acquisition were controlled by Simple PCI software (Compix). For each fluorophore, a montage of
110 images (using a x10 objective) was created for reconstruction of each cross section. Where indicated, confocal images were acquired using a Leica TCS SP2 confocal microscope with either a x40 or x100 objective. Total magnification is given in each figure.
| RESULTS AND DISCUSSION |
|---|
|
|
|---|
A-TRPCx. In the present study, a second set of antibodies, designated
B-TRPCx, was generated in rabbits against a different peptide sequence in each rat TRPC channel protein (Supplementary Table 1). The complete characterization of the TRPC antibodies with regard to specificity, selectivity, and usefulness as probes for immunoprecipitation, immunoblot, and immunohistochemical analysis can be found in the Supplementary Materials.
The overall approach used to determine the presence and localization of each TRPC channel protein in the kidney was as follows. The presence of each channel was first determined by immunoprecipitation followed by Western blot analysis. This was followed by immunofluorescence analysis of whole kidney cross sections, which provided the initial indication of localization within the nephron. Next, colocalization of each identified TRPC channel protein with specific marker proteins was used to localize the TRPCs to specific cell types within the nephron. Finally, comparison of TRPC subcellular distribution with that of the NKA pump was used to determine localization to apical or basolateral membranes. Once the in vivo distribution was established, we selected several cell lines from different regions of the nephron to examine TRPC channel expression for future use as in vitro model systems. With noted exceptions (differences between
A- and
B-antibodies are noted in all sections, except the last section where no differences were found), all of the biochemical and immunohistochemical results presented in this paper have been confirmed using both the
A-TRPCx and
B-TRPCx antibodies. With regard to controls, incubation of kidney tissue and cell lysates with protein A/G beads alone (i.e., no primary antibody) or preincubation of the primary antibodies with the immunizing peptide prevented pull-down of the channel proteins as determined by subsequent immunoblots. For immunofluorescence assays, preincubation of the primary antibodies with the appropriate immunizing peptide, or incubation of kidney sections with only the secondary antibody, reduced fluorescence to nondetectable levels. These controls confirm that the results presented below are specific.
With the use of both
A-TRPCx and
B-TRPCx antibody preparations, TRPC4, TRPC5, and TRPC7 were nondetectable in immunoprecipitation or immunohistochemical assays. This result was obtained in vivo in rat, dog, and mouse kidney, in cultured rat podocyte and mesangial cells, and in cultured mouse M1 and IMCD3 collecting duct cells. Our inability to detect these channels may indicate that 1) their expression level is below the limit of our detection, 2) the epitopes recognized by these antibodies are hidden/blocked in native tissues, or 3) the epitopes are missing due to splice variant expression. It seems unlikely, however, that the epitopes for both
A- and
B-antibodies would be blocked or missing in these proteins. Furthermore, the
A-antibodies have been used for identification of TRPC channels in rat brain (2, 9). Thus TRPC4, TRPC5, and TRPC7 channels are probably absent or below the limit of detection in the kidney. Three reports of TRPC4 protein in renal tissue have been published to date (5, 15, 36). These studies employed commercially available antibody preparations for the identification of TRPC4 protein. However, it has recently been shown that the anti-TRPC4 antibody from Alomone Labs (Jerusalem, Israel) recognizes a protein with the appropriate molecular mass in lysates from TRPC4 knockout mice (6). Thus results with this antibody should be viewed with caution. TRPC4, -C5, and -C7 will not be discussed further.
Distribution of TRPC1 in the kidney.
Kidney lysates were subjected to immunoprecipitation using both
A-TRPC1 and
B-TRPC1. As seen in Fig. 1B, a single band at a molecular mass expected for full-length TRPC1 was immunoprecipitated and recognized by both TRPC1 antibodies. To determine which cells express TRPC1, cross sections of rat kidney were stained with both
A- and
B-TRPC1 antibodies. In contrast to the immunoprecipitation and Western blot results, only
B-TRPC1 yielded labeling profiles consistent with specific cell-associated immunoreactivity in the kidney. Immunofluorescence analysis using
B-TRPC1 showed, however, that TRPC1 was present in glomeruli, and specific tubules of the renal cortex and outer medulla, but was essentially absent from the inner medulla (Fig. 1A). To begin to determine the exact location of TRPC1 in the nephron, we compared the distribution of TRPC1 with that of AQP1, which is expressed in regions of the proximal tubule and descending thin limb, and with AQP2 which is found in connecting tubule (CNT) and collecting duct (CD) cells (21). No colocalization was observed with AQP2 (Supplementary Fig. 4); however, colabeling of TRPC1 (green) with AQP1 (red) indicated nearly perfect colocalization (yellow) in tubular elements throughout the cortex (Fig. 2). The high-magnification merged image shows that TRPC1 is highly expressed in the apical brush-border regions of the proximal tubule cells along with AQP1. The AQP1 labeling in the inner medulla presumably reflects the thin descending limb. Thus TRPC1 expression appears to be restricted to the glomerulus and proximal tubule. However, as seen in Fig. 2, the outer stripe of the inner medulla is predominantly green; i.e., TRPC1 is expressed in tubules that do not express either AQP1 or AQP2.
|
|
|
95 kDa was observed in immunoprecipitates from medullary lysates. Both antibodies immunoprecipitate and recognize the same protein in the medulla. Immunoprecipitations from glomerular and tubular lysates from the cortex also showed the same 95-kDa band with both the
A- and
B-TRPC3. However, an additional higher-molecular-weight band at
120 kDa was observed when the immunoprecipitated proteins were probed with
B-TRPC3 (Fig. 3A, bottom right), suggesting the possible presence of an additional splice variant of TRPC3 channel protein. According to a recent report (39), there is a TRPC3 splice variant (TRPC3a) with an extra exon at the 5'-end of the gene, adding an additional 62 amino acids to the murine homolog. However, the observation that this band is not recognized by the
A-TRPC3 antibody on Western blot analysis suggests that it may be unrelated to TRPC3. Distinct immunopositive labeling for TRPC3 was detected in both the cortical and medullary regions of the kidney (Fig. 3). In both the cortex and medulla, TRPC3 localization was predominantly confined to the apical domain of specific tubular cells. In the cortex, TRPC3 was localized to the glomeruli. This is consistent with a recent study reporting TRPC3 mRNA in isolated glomeruli (5). Given the results obtained by Western blot analysis, it is important to reemphasize that the same immunohistochemical profile was observed using both the
A-TRPC3 and
B-TRPC3 antibodies.
|
A-TRPC6 and
B-TRPC6 showed an immunoreactive band of
110 kDa (Fig. 4). However, immunoprecipitations from glomeruli showed the presence of an immunoreactive TRPC6 band of
90 kDa. According to a previous report (41), rats express full-length and two splice variant forms of TRPC6, with predicted molecular masses of 107, 98, and 87 kDa. Thus it is possible that cells of the glomerulus predominantly express one of the shorter TRPC6 splice variants, whereas the full-length form predominates in tubular cells of the renal cortex and medulla. Immunofluorescence analysis revealed that TRPC6 channel protein distribution was similar to that of TRPC3. TRPC6 was present in the glomerulus and in specific cells of the cortex and both the outer and inner medulla (Fig. 4). Association of TRPC6 with cells of the glomerulus is consistent with recent reports demonstrating a role for TRPC6 in focal segmental glomerulosclerosis (25, 37). In high-magnification images of tubule cells, TRPC6 appeared to localize to both the apical and basolateral domains. Kidney sections were individually colabeled for TRPC3 or TRPC6 and AQP1 or AQP2. Neither TRPC3 nor TRPC6 localized with AQP1 (Supplementary Fig. 5). However, both proteins were found in cells expressing AQP2 (Fig. 5). AQP2 is abundant in the apical region of the principal cells of the CD and at lower abundance in cells of the CNT (21). At higher magnification, TRPC3 labeling appeared predominantly at the apical membrane, although some intracellular labeling is evident in most images. TRPC6 immunofluorescence was detected in both the apical and basolateral membranes and, like TRPC3, may also be present in the cytosol. To distinguish between CNT and CD, we compared the distribution of TRPC3 and TRPC6 with the NCX. The NCX is present in distal convoluted tubule and in CNT, but its expression abruptly stops in the cortical CD (17, 18). Consistent with this distribution, NCX immunofluorescence was seen in the cortex, but was absent from the inner medulla (Fig. 6). Neither TRPC3 nor TRPC6 colocalized with NCX. Thus TRPC3 and TRPC6 appear to be highly expressed in cells of the cortical and medullary CD. The CD is made up of two primary cell types, principle cells and intercalated cells. The principle cells express AQP2 and are thought to be involved in vasopressin-regulated water transport, whereas the intercalated cells express the H+-ATPase and are thought to play a role in acid secretion (19). Peanut lectin is a marker for intercalated cells (16). Neither TRPC3 nor TRPC6 colocalized with peanut lectin (data not shown), suggesting that both channel proteins are primarily expressed in the principle cells of the CD.
|
|
|
|
|
|
|
| GRANTS |
|---|
|
|
|---|
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
| REFERENCES |
|---|
|
|
|---|
causes rapid activation of cytosolic phospholipase A2 by phosphorylation in rat mesangial cells. J Clin Invest 93: 12241233, 1994.[ISI][Medline]This article has been cited by other articles:
![]() |
M. R. Quinlan, N. G. Docherty, R. W. G. Watson, and J. M. Fitzpatrick Exploring mechanisms involved in renal tubular sensing of mechanical stretch following ureteric obstruction Am J Physiol Renal Physiol, July 1, 2008; 295(1): F1 - F11. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Niehof and J. Borlak HNF4{alpha} and the Ca-Channel TRPC1 Are Novel Disease Candidate Genes in Diabetic Nephropathy Diabetes, April 1, 2008; 57(4): 1069 - 1077. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Galizia, M. P. Flamenco, V. Rivarola, C. Capurro, and P. Ford Role of AQP2 in activation of calcium entry by hypotonicity: implications in cell volume regulation Am J Physiol Renal Physiol, March 1, 2008; 294(3): F582 - F590. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Goel, W. G. Sinkins, C.-D. Zuo, U. Hopfer, and W. P. Schilling Vasopressin-induced membrane trafficking of TRPC3 and AQP2 channels in cells of the rat renal collecting duct Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1476 - F1488. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Beskina, A. Miller, A. Mazzocco-Spezzia, M. V. Pulina, and V. A. Golovina Mechanisms of interleukin-1beta-induced Ca2+ signals in mouse cortical astrocytes: roles of store- and receptor-operated Ca2+ entry Am J Physiol Cell Physiol, September 1, 2007; 293(3): C1103 - C1111. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Liu, T. Morimoto, C. Woda, T. R. Kleyman, and L. M. Satlin Ca2+ dependence of flow-stimulated K secretion in the mammalian cortical collecting duct Am J Physiol Renal Physiol, July 1, 2007; 293(1): F227 - F235. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Du, S. Sours-Brothers, R. Coleman, M. Ding, S. Graham, D.-H. Kong, and R. Ma Canonical Transient Receptor Potential 1 Channel Is Involved in Contractile Function of Glomerular Mesangial Cells J. Am. Soc. Nephrol., May 1, 2007; 18(5): 1437 - 1445. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Nilius, G. Owsianik, T. Voets, and J. A. Peters Transient Receptor Potential Cation Channels in Disease Physiol Rev, January 1, 2007; 87(1): 165 - 217. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sours, J. Du, S. Chu, M. Ding, X. J. Zhou, and R. Ma Expression of canonical transient receptor potential (TRPC) proteins in human glomerular mesangial cells Am J Physiol Renal Physiol, June 1, 2006; 290(6): F1507 - F1515. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||